Katsuyoshi Habiro
3PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Apr 30, 2025
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: In-Depth Analysis of Efficacy and Safety in the Phase 3 POETYK PSO-4 Trial.Yukari Okubo, Akimichi Morita, Shinichi Imafuku
|Mar 11, 2025
Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO-1, PSO-4, and LTE trials.Akimichi Morita, Shinichi Imafuku, Yayoi Tada
|Nov 30, 2023
Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review.Yayoi Tada, Mayumi Komine, Yukari Okubo
Pageof 1
